스포츠중계해골TV OSAKA, JAPAN & CAMBRIDGE, MASS.--( / )--Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for fiscal year 2022 (period ended March 31, 2023), delivering or exceeding management guidance, driven by the performance of its Growth & Launch Products.
Takeda president and chief executive officer, Christophe Weber, commented:
“FY2022 was another strong year for Takeda, reflecting successful execution against our business strategy and advancements in our innovative pipeline?enabling us to deliver truly transformative treatments to patients. Important pipeline milestones included the first approvals for our dengue vaccine QDENGA®, positive late-stage readouts for TAK-755 and fazirsiran, and the acquisition of TAK-279 for immune-mediated diseases.
“We have updated our capital allocation policy as a reflection of our deleveraging progress and our new phase of investment for growth and shareholder returns. We have adopted a progressive dividend policy of increasing or maintaining the dividend each year, and in FY2023 we intend to raise the dividend to underscore confidence in our future growth profile.
“While we expect to face temporary headwinds in FY2023 from generic entrants and lower demand for coronavirus vaccines, we are confident that strong momentum in our Growth & Launch Products will drive a return to growth in the near-term. We will continue to strengthen our long-term competitiveness through investments in R&D and data and technology, as we deliver on our purpose to bring better health for people and a brighter future for the world.”
Takeda chief financial officer, Costa Saroukos, commented:
“I’m pleased to report that Takeda delivered or exceeded management guidance in FY2022 and booked a record core operating profit of almost 1.2 trillion yen. Our topline and profit performance was driven by our Growth & Launch Products, which grew 19% at constant exchange rate.
“Strong financial discipline and free cash flow have enabled us to deleverage rapidly while investing in growth. As a result, we are forecasting a dividend increase for the first time in 15 years, from 180 yen to 188 yen per share.
“Our outlook for FY2023 reflects the challenges of anticipated generic impact and lower coronavirus vaccine contributions, but we still anticipate delivering core operating profit above 1 trillion yen. Our forecasted reported EPS growth rates are also impacted by one-time items which are not reflective of our core business momentum. We remain confident in our future growth outlook and our planned dividend increase underscores that confidence.”
FINANCIAL HIGHLIGHTS
Results for FY2022 Ended March 31, 2023
(To view the table, please visit )
COMMERCIAL UPDATES ACROSS FIVE KEY BUSINESS AREAS
Growth in Takeda’s key business areas in FY2022 was driven largely by Growth & Launch Products[1], which delivered reported revenue of 1,594.8 billion yen, marking a 19% increase on a constant exchange rate (CER) basis.
· Gastroenterology (GI), with 1,094.5 billion yen in reported revenue, grew 8.7% on a CER basis driven by ENTYVIO® (for ulcerative colitis (UC) and Crohn’s disease (CD)), which is expanding through continued launches of the subcutaneous formulation, and in the U.S. has become the number one biologic for inflammatory bowel disease (UC and CD combined, supported by quarterly share data that better accounts for differences in dosing schedules).
· Rare Diseases, with 723.4 billion yen in reported revenue, grew 4.8% on a CER basis. Sales of TAKHZYRO® (for hereditary angioedema (HAE)) grew 25% on a CER basis, primarily due to expansion of the prophylactic market, continued geographic expansion and strong patient demand. Sales of LIVTENCITY® (for post-transplant cytomegalovirus infection/disease) were 10.5 billion yen, driven by the strong launch momentum in the U.S. and geographic expansion with the European Commission granting approval in November 2022.
· Plasma-Derived Therapies (PDT) Immunology, with 678.4 billion yen in reported revenue, delivered outstanding growth of 15.3% on a CER basis. Growth was driven by higher sales of immunoglobin products (for primary immunodeficiency, multifocal motor neuropathy and subcutaneous immunoglobin therapies), with 16% growth on a CER basis, particularly in the U.S. amid easing of pandemic pressures coupled with increasing supply. Robust growth for albumin products (primarily used for hypovolemia and hypoalbuminemia), at 19% on a CER basis, was driven by strong demand in the U.S. and China.
· Oncology, with 438.7 billion yen in reported revenue, declined 14.4% on a CER basis as a result of the entry of multiple VELCADE® generics that began in the U.S. in May 2022. Besides VELCADE, all other revenue totaled 411.0 billion yen, a year-over-year increase of 5% on a CER basis, mainly driven by ADCETRIS® (for malignant lymphomas), which grew 14% on a CER basis, due to growth in Argentina, Italy, and Japan. ALUNBRIG® (for non-small cell lung cancer) also grew 35% on a CER basis with strong demand in Europe, China, and Growth & Emerging Markets. During FY2022, EXKIVITY® was approved for EGFR exon20 insertion+ non-small cell lung cancer in China, and both ALUNBRIG and ADCETRIS were included in the 2022 National Reimbursement Drug List in China.
· Neuroscience, with 637.7 billion yen in reported revenue, grew 12.1% on a CER basis, driven by increased adult ADHD demand for VYVANSE® in the U.S., Europe, and Canada for VYVANSE/ELVANSE. Sales of TRINTELLIX grew at 2% on a CER basis due to strong market share gains in Japan, while demand in the U.S. grew in line with the anti-depressant market growth.
PIPELINE UPDATE
Takeda has continued to deliver on its ability to bring new therapies to patients and capitalize on existing momentum within its dynamic and diverse pipeline. Updates since the FY2022 Q3 announcement include:
· The U.S. Food and Drug Administration (FDA) approved the supplemental Biologics License Application (sBLA) for the expanded use of TAKHZYRO (lanadelumab-flyo) for prophylaxis to prevent attacks of HAE in pediatric patients 2 to <12 years of age. Prior to this approval, the only approved routine prophylaxis treatment options for children 6 to <12 years of age required dosing every three to four days. Children with HAE 2 to <6 years of age had no approved prophylaxis treatment, making TAKHZYRO the first prophylaxis treatment option for this age group.
Additional information related to this announcement is available here.
· A Phase 2b study of TAK-279, a highly selective once-daily oral tyrosine kinase 2 (TYK2) inhibitor, showed positive results in patients with moderate-to-severe plaque psoriasis. The study met its primary and secondary endpoints, and 33% of patients achieved clear skin at 12 weeks (PASI 100) at the highest dose (30mg). Most adverse events were mild to moderate in severity. TAK-279 will progress to a Phase 3 study in psoriasis in FY2023. Additionally, Takeda expects topline results from a Phase 2b study of TAK-279 for psoriatic arthritis in FY2023.
Additional information related to this announcement is available here.
· QDENGA, Takeda’s dengue vaccine, which has received several approvals to date, was most recently approved by Brazil’s National Health Surveillance Agency (ANVISA) in March 2023 for use in individuals between 4 years and 60 years to protect against all four serotypes. QDENGA is the only dengue vaccine that is approved for use regardless of previous exposure and without need of pre-vaccination testing. This approval marks the first approval of QDENGA in Latin America as Takeda continues to progress additional regulatory filings in other dengue-endemic countries.
Additional information related to this announcement is available here.
· ENTYVIO subcutaneous injection received manufacturing and marketing approval in Japan as a maintenance therapy for patients with moderate to severe ulcerative colitis who have had inadequate response to conventional treatment.
Additional information related to this announcement is available here.
· Results from Phase 4 EARNEST study of vedolizumab (ENTYVIO) demonstrated efficacy and met primary endpoints in the treatment of chronic or recurrent pouchitis. Primary endpoints were met with vedolizumab patients achieving remission at weeks 14 and 34 as compared to placebo. The New England Journal of Medicine published the data in an article titled “Vedolizumab for the Treatment of Chronic Pouchitis.”
Additional information related to this announcement is available here.
· The U.S. FDA has accepted for review its Biologics License Application (BLA) resubmission in April 2023 for the investigational subcutaneous administration of ENTYVIO (vedolizumab) for maintenance therapy in adults with moderately to severely active UC after induction therapy with Entyvio intravenous.
Additional information related to this announcement is available here.
OTHER NOTABLE PROGRESS
Takeda is committed to creating long-term value consistent with our corporate values. Significant social and environmental sustainability milestones in FY2022 include:
· At the World Economic Forum Annual Meeting 2023, Takeda signed the Global Health Equity Network Zero Health Gaps Pledge reinforcing the company’s commitment to identify global inequities and deliver solutions to address them. Additionally, Takeda continues to make progress in fostering an inclusive ecosystem where everyone has access to equitable care including efforts ranging from early access and patient assistance programs to driving clinical trial diversity efforts with the Pharmaceutical Research and Manufacturers of America (PhRMA) and a partnership with Discovery Education, a worldwide edtech leader, that nurtures a health equity mindset for students and educators.
· Takeda’s aspiration is to also create an environment that encourages lifelong learning and a growth mindset, enabling our people to thrive inside and outside of Takeda. To provide opportunities for individual, personalized learning, and career growth we introduced Bloom LXP, an online learning experience platform which provides a single-entry point for all learning at Takeda in October 2022. This platform has been accessed by over 65% of our employees since its launch.
· The company also completed a virtual power purchase agreement with Enel North America for its Seven Cowboy Wind Project, which is now operational. Through the agreement, Takeda is expected to create up to 350,000 megawatt hours (MWh) of renewable energy and associated credits per year, accounting for approximately 20% of Takeda’s current enterprise-wide scope 1 and 2 greenhouse gas (GHG) emissions. In accordance with the Science Based Targets initiative’s Corporate Net-Zero Standard, the agreement also accelerates Takeda’s progress towards its goal to be net-zero in its operations (scopes 1 and 2) before 2035 and underscores the company’s commitment to delivering a high standard of environmental leadership as climate change and pollution both impact patient and human health.
FY2023 Outlook
(To view the table, please visit )
About Takeda
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare disease, plasma-derived therapies, neuroscience, oncology and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit
Important Notice
For the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this press release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws.
The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies.
The product names appearing in this document are trademarks or registered trademarks owned by Takeda, or their respective owners.
Forward-Looking Statements
This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could”, “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations, including global health care reforms; challenges inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business; the timing and impact of post-merger integration efforts with acquired companies; the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s); the extent to which our internal energy conservation measures and future advancements in renewable energy or low carbon energy technology will enable us to reduce our greenhouse gas emissions; and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: or at Takeda does not undertake to update any of the forward-looking statements contained in this report or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this report may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results.
Financial information and Certain Non-IFRS Financial Measures
Takeda’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”).
This press release and materials distributed in connection with this press release include certain financial measures not presented in accordance with IFRS, such as Core Revenue, Core Operating Profit, Core Net Profit, Core EPS, Constant Exchange Rate (“CER”) change, Net Debt, EBITDA, Adjusted EBITDA and Free Cash Flow. Takeda’s management evaluates results and makes operating and investment decisions using both IFRS and non-IFRS measures included in this presentation. These non-IFRS measures exclude certain income, cost and cash flow items which are included in, or are calculated differently from, the most closely comparable measures presented in accordance with IFRS. By including these non-IFRS measures, management intends to provide investors with additional information to further analyze Takeda’s performance and core results, including when controlling for the effect of fluctuations in exchange rates. Takeda’s non-IFRS measures are not prepared in accordance with IFRS and such non-IFRS measures should be considered a supplement to, and not a substitute for, measures prepared in accordance with IFRS (which we sometimes refer to as “reported” measures). Investors are encouraged to review the definitions and reconciliations of non-IFRS financial measures to their most directly comparable IFRS measures, which are in the financial appendix at the end of Takeda's FY2022 investor presentation (available at takeda.com/investors/financial-results).
Medical information
This press release contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, in different dosages, or in different strengths. Nothing contained herein should be considered a solicitation, promotion or advertisement for any prescription drugs including the ones under development.
[1] Please refer to slide 20 of Takeda’s FY2022 investor presentation (available at takeda.com/investors/financial-results) for the definition of Growth & Launch Products.
View source version on businesswire.com:Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network
HYOGO, JAPAN--( / )--PanaHome Corporation, 릴게임프로그램 성인주민번호 ENERES Co., Ltd, IBJ Leasing 해남홀덤펍 수빈이넷 Co., Ltd. and the Public Enterprises Agency of 릴게임추천사이트 HYOGO,Hyogo Prefectural Government plan to embark 해남홀덤펍 썰저장소 on the urban development of a microgrid system (a regional energy distribution management system) 해남홀덤펍 윈도우xp프린터공유 (*1) 릴게임프로그램 윈도우7프린터 starting October 2017.
[Video] Launch of Japan's First Microgrid System 릴게임프로그램 뷰토렌트 릴게임추천사이트 [Video]a Total of 117 릴게임프로그램 야동패치 해남홀덤펍 야동패치 Homes 릴게임프로그램 사노아오이 - Smart City Shioashiya
The microgrid system will power a total of 해남홀덤펍 파일구리방화벽 117 해남홀덤펍 파일구리공유폴더 homes in Zone D4 of Smart City Shioashiya Solar-Shima, which is being designed and developed by PanaHome in Ashiya City, Hyogo Prefecture. On August 9, 2017, the project was selected 바카라게임다운로드 The해남홀덤펍 a part of the Ministry of Economy, Trade and Industry's subsidy program to promote local energy production 릴게임프로그램 주민등록번호공유 for local consumption by leveraging regional characteristics.
This is a joint project being carried out by PanaHome, ENERES, IBJ Leasing and the Public Enterprises Agency. The project concept is a “town interconnected by energy 릴게임프로그램 편지지프린트 for living.” PanaHome purchased land that was developed by the Public Enterprises Agency. Panasonic Corporation and the City of Ashiya are also cooperating with the development of this project. A part of the project entails building 써니넷 Thisfirst (*2) microgrid system. Solar energy will be used to power 80% or more (*3) of the entire housing district. This will be made feasible by running private power distribution lines (*4) to the housing district and sharing power between homes. Even when the district becomes disconnected from the traditional electrical grid during emergencies, the private power distribution lines can continue to supply power via specific circuits. Private power distribution lines make it possible to receive power and flexibly set power rates. Consequently, this poses a number of benefits for homeowners including, a 20% cut in their electricity bill. Another key goal is to contribute to the environment, mainly by maximizing use of renewable energy to reduce CO2 emissions. Going 해남홀덤펍 forward this project 해남홀덤펍 페이스북플리커 will contribute to solutions for sharing electric power between buildings, preventing blackouts in areas overseas where power grids are weak, and in showcasing these solutions overseas.
[Responsibilities of 해남홀덤펍 이메일 스포츠중계비비TV [Responsibilities릴게임프로그램 해남홀덤펍 project participant] 릴게임프로그램 oneshot 해남홀덤펍 oneshot
Applicants 릴게임프로그램 피카사 해남홀덤펍 피카사
PanaHome (Main 릴게임프로그램 실전게임 스포츠중계비비TV PanaHome릴게임프로그램 승리허리돌리기 해남홀덤펍 승리허리돌리기
Design, development, 해남홀덤펍 홀덤사이트 housing 야동망고 Design,and overall planning of the smart 해남홀덤펍 유이허리돌리기 city 릴게임프로그램 소희허리돌리기 해남홀덤펍 소희허리돌리기
킨제이헵스후기 ENERES해남홀덤펍 허리돌리는법 (Joint applicant) 릴게임프로그램 실시간토토 해남홀덤펍 실시간토토
Energy 릴게임프로그램 허리돌리기운동 management services 해남홀덤펍 제시카허리돌리기
성인인형풍선사용후기 IBJ릴게임프로그램 올인구조 Leasing 릴게임프로그램 먹튀검증 해남홀덤펍 먹튀검증 (Joint 해남홀덤펍 여자허리돌리기 applicant) 릴게임프로그램 해남홀덤펍
Own and manage private 릴게임프로그램 총판모집 해남홀덤펍 총판모집 power distribution 성인섹스기구사용후기 Own
Hyogo 릴게임프로그램 토토홍보 Public 해남홀덤펍 첫충 Enterprises 해남홀덤펍 매충 Agency (Joint applicant) 해남홀덤펍 김태희비
Residential 해남홀덤펍 land development 릴게임프로그램 and regional cooperation 해남홀덤펍
스트롱매직사용후기 [Partners]릴게임프로그램 뉴원더풀홀덤 해남홀덤펍 뉴원더풀홀덤
City 릴게임프로그램 김태희를보게된일본인들의표정 of Ashiya, 릴게임프로그램 김태희유아인 영등포동8가성인게임장 City해남홀덤펍 원샷홀덤사이트 Prefecture
Regional 릴게임프로그램 하이로우게임 해남홀덤펍 하이로우게임 collaboration for urban development 릴게임프로그램 김태희키스신 of 해남홀덤펍 김태희 Shioashiya
CAHEo Panasonic릴게임프로그램 해남홀덤펍 Corporation 해남홀덤펍 김태희섹시화보
광산구홀덤펍 Collaborationon power storage 해남홀덤펍 홀덤규칙 management systems, technical 릴게임프로그램 김태희아프리카사건 support, and the safety and 해남홀덤펍 현금홀덤 management of private power distribution 해남홀덤펍 홀덤바 lines
[Background] 릴게임프로그램 해남홀덤펍
In the wake of the Great East Japan earthquake, demand emerged for the introduction of distributed energy systems highly resilient to disasters. The quake made it apparent that 릴게임프로그램 centralized energy 릴게임프로그램 허벅지노출 systems were vulnerable to such disasters. Meanwhile, it has also become necessary to flexibly offset the unstable supply of electric power with a considerable expansion in the use 산정동고스톱 Inrenewable energy. In addition, there is a need to shift from the wider use of solar power via the feed-in tariff (FIT) scheme, 릴게임프로그램 to the expanded use of solar power sources via the effective use of local energy production 해남홀덤펍 방자전 for local consumption.
Since 1998, Hyogo 중노송동홀덤카페 Sinceand the City of Ashiya have been carrying out development in the Shioashiya area, which is in the Minami Ashiya-hama district, based on 해남홀덤펍 팔찌추천 the concept of urban development that connects 릴게임프로그램 에뛰드하우스추천 people. From 2012, PanaHome embarked on the development 릴게임프로그램 자동차추천 of Smart City Shioashiya Solar-Shima, which is comprised of roughly 400 individual homes and 3 condominium complexes (total of 83 condos). The company's highly energy-efficient buildings and its large-scale urban development which maximizes the use 릴게임프로그램 of renewable energy has won the company high praise, even from overseas. The company recently won a Gold Award in the “Smart Buildings” category of the 3rd APEC (Asia Pacific Economic Cooperation) ESCI (*5) 해남홀덤펍 구루마넷 Best Practice Awards.
[Overview of the microgrid 거래소 [Overviewand 릴게임프로그램 미인도 the specified supply 릴게임프로그램 해남홀덤펍 (*6) 해남홀덤펍 몽키넷 scheme] 릴게임프로그램 보지넷 해남홀덤펍 보지넷
A solar power generator (4.6kW), 가상화폐쇼핑몰 Acell (11.2kWh) and HEMS (*7) has been installed in each of the homes in this project. Within the housing district, each home's storage 릴게임프로그램 현자타임스 cell is connected by private 해남홀덤펍 레드썬 power distribution lines. The storage cell control unit makes it possible to reverse 릴게임프로그램 부산여자 the power flow current and mutually share electric power between homes. This is the first such microgrid system (regional energy distribution system) in Japan.
Specified 릴게임프로그램 포항아이롱다운펌 supply scheme using private power 릴게임프로그램 성남아이롱다운펌 distribution lines 해남홀덤펍 안산아이롱다운펌
The 전자화폐와결제시스템 Theassociation consists of homeowners of the 117 해남홀덤펍 인천아이롱다운펌 homes in the residential district. The management association has outsourced the power storage cell control management to ENERES, 릴게임프로그램 AVDBS a company with expertise in this area. Based on a specified supply scheme to control 해남홀덤펍 부평미용실 the supply of 릴게임프로그램 헨타이폭스 power from storage cells to association members (residents), it will be possible to operate an EMS (*8) system 릴게임프로그램 챨스헤어 and provide power coverage to the entire 해남홀덤펍 송중기고향 district by employing IBJ Leasing's environmental solutions, which were derived from its financial knowhow, to introduce private power distribution lines.
Business location: 해남홀덤펍 온라인채팅 비트코인1개 Business릴게임프로그램 chaturbate 해남홀덤펍 chaturbate City Shioashiya 릴게임프로그램 헤어스타일링제품 Zone D4
Site: 해남홀덤펍 beeg Suzukaze-cho, Ashiya, Hyogo, 릴게임프로그램 스타일미용실 Japan
Coverage: 릴게임프로그램 수지광주 Smart City Shioashiya 해남홀덤펍 이태임 Zone D4
프로겜블러 Main릴게임프로그램 해남홀덤펍 renewable energy: Roughly 해남홀덤펍 레드튜브 32,007.92 m2
Shared 릴게임프로그램 트위스터 해남홀덤펍 트위스터 energy: 릴게임프로그램 특수머리 해남홀덤펍 특수머리 세븐포커어플 Shared릴게임프로그램 power
게임사이트카지노추천 Startof operations: 릴게임프로그램 대전붙임머리 해남홀덤펍 대전붙임머리 October 릴게임프로그램 javbro 2018 해남홀덤펍 asiav
[Features 해남홀덤펍 대전미용실 of the 릴게임프로그램 javhdmovies microgrid system] 해남홀덤펍 watchjavonline
1. 릴게임프로그램 포르노허브 Low 릴게임프로그램 javbraze power rates and free 릴게임프로그램 대구출신아이돌 power control owing to the use of 해남홀덤펍 javqd private power distribution lines
The 해남홀덤펍 javfun use of private power distribution lines makes it possible to freely control the receipt 릴게임프로그램 대도초등학교 of 릴게임프로그램 민효린대구 electric power and storage cells in the housing district and to flexibly set 퀴즈 Therates. Furthermore, it will be possible to reduce 해남홀덤펍 부산출신가수 power rates by 20% by improving the rate of self-sufficiency on 릴게임프로그램 바나나샵 renewable energy by sharing power between 해남홀덤펍 일본미국 homes.
2. Equalize supply-demand 릴게임프로그램 카지노바카라 balance 해남홀덤펍 오나왕 for 릴게임프로그램 카지노바카라게임 해남홀덤펍 카지노바카라게임 electric power in the district via regional control of storage cells
Peak demand for power will be controlled within the area through 해남홀덤펍 the regional control of storage cells connected by the private power distribution lines. By entering 해남홀덤펍 에이플러스카지노 into contracts for receiving power 해남홀덤펍 비비카지노 with new power companies (hereinafter referred to 나체 Peaka PPS (*9)), when it is expected that the area will exceed its contracted power supply, the system orders a discharge 릴게임프로그램 무비랑 of electric power to equalize the supply of electric power.
3. Continued power 릴게임프로그램 티비나무 supply even if supply 해남홀덤펍 바카라주소 from main grid 해남홀덤펍 바카라싸이트 is 릴게임프로그램 suspended (designated circuit)
During normal energy usage, the entire district will maximize use of solar power. When there is shortage of electric power, renewable energy will be supplied over the PPS grid (FIT power source (*10)) to maintain a stable 해남홀덤펍 VOD79 power supply. During an emergency where the main power grid is 해남홀덤펍 interrupted, it is possible to continue to supply power to homes in 릴게임프로그램 에바그린 the district by supplying power to designated circuits (refrigerators, lighting, cell phone rechargers, 릴게임프로그램 etc.) from power storage in storage cells or solar power generated within the district.
[Overview 릴게임프로그램 에이스 of shared 해남홀덤펍 power among homes 해남홀덤펍 월드카지노 in the district] 해남홀덤펍
In this project, all homes are equipped with solar power generators, storage cells, and HEMS. The storage cells installed in 릴게임프로그램 토렌트유 each home are connected to form a 릴게임프로그램 토렌트야 network. The power stored in the storage 해남홀덤펍 freeporn cells (11.2kWh) can be shared by the 117 homes in the district. It is as if there is a giant storage cell with 1.3MWh of power. Homes with surplus electricity can share with homes that have a shortage of power. This reduces the need to purchase energy from external sources and maximizes the use of solar 나체 Ingenerated within 릴게임프로그램 photo the district.
[Expected 릴게임프로그램 joyclub 해남홀덤펍 joyclub benefits] 해남홀덤펍 69
1. Self-sufficiency rate of 릴게임프로그램 gangbang 80% or higher owing to the local production 릴게임프로그램 경마왕 and 나체 1.consumption of solar power 해남홀덤펍 한게임 (environmental benefit)
2. 릴게임프로그램 클럽 A 20% reduction in electric power 릴게임프로그램 ERO 나체 2.owing to 릴게임프로그램 japansex receipt 해남홀덤펍 pornvideo of power and storage cell control (economic 해남홀덤펍 benefit)
3. 100% use of renewable 릴게임프로그램 show energy (solar power generated in the district and FIT 릴게임프로그램 리버풀 source outside the 릴게임프로그램 ENJOY housing district) (environmental 해남홀덤펍 한게임포커 benefit)
4. Possible 해남홀덤펍 포카 to supply power even when power supply from the main grid 캐나다복권 4.해남홀덤펍 테이블 been interrupted 릴게임프로그램 (designated 해남홀덤펍 마카오여행 circuits) (dealing 릴게임프로그램 soranet with disasters)
5. 해남홀덤펍 프로농구 다시보기 5.릴게임프로그램 ECHAT power supply 릴게임프로그램 강원랜드주가 within 릴게임프로그램 DIEHD the district (social benefit)
[Hybrid deployment 릴게임프로그램 lovesex of microgrid VPP (*11) 릴게임프로그램 feasibility 해남홀덤펍 test] 해남홀덤펍 sexymassage
In addition to the deployment of a microgrid, a feasibility test will be conducted for the VPP control unit. When instructions, including demand response (*12) orders from the resource aggregator (*13), come from above, the goal is to control the inflow and outflow 릴게임프로그램 스포츠토토배당률 of power from storage cells in each home 릴게임프로그램 베트멘토토 to address the increase or decrease of power consumption in the district, as if it 해남홀덤펍 스완지시티 were all functions as one power generator.
Notes: 릴게임프로그램 해남홀덤펍
*1. A small-scale power grid. A small 릴게임프로그램 축구게임 power generator facility, including solar power generator, is set up in an area to supplement power demand using a 해남홀덤펍 local production, local consumption model.
*2. It is Japan's first 릴게임프로그램 토토배당률 point that makes to share electric power mutually 해남홀덤펍 at 117 homes by running private distribution lines in the housing district.
*3. (Amount of solar 릴게임프로그램 Xvd2 power consumed privately + amount of surplus power shared) ÷ Total power consumption (Annual basis; based on a 해남홀덤펍 토토분석 simulation performed by PanaHome) 릴게임프로그램
*4. Power distribution 릴게임프로그램 유토파일 lines privately installed to 릴게임프로그램 네임드사다리 supply power 해남홀덤펍 without relying on general power distribution companies.
*5. Energy Smart 릴게임프로그램 Communities Initiative (ESCI): Network launched in 2010 at the Yokohama APEC meeting. APEC member countries and regions collaborate on projects in 해남홀덤펍 메가카지노 five fields - smart buildings, smart grid, low-carbon model town, smart job and consumer, and smart transport - through the introduction of new technologies.
*6. Article 17 of the ElTanqueSisley *6.Business Act (Specified Supply): System whereby 릴게임프로그램 타이젬 an electric 해남홀덤펍 뉴토끼 power supplier that meets 릴게임프로그램 부산경륜 certain criteria 릴게임프로그램 몽키코믹스 obtains a license for each location to which they plan to supply power and supplies power to that specific target.
*7. Home 해남홀덤펍 Energy Management 릴게임프로그램 움짤/연예인 System (HEMS): Energy usage 릴게임프로그램 REBLOP *7.not only made transparent but also optimally controls electric use of consumer 해남홀덤펍 일반인 electronics and electrical facilities installed in 릴게임프로그램 헬로바카라추천 the 해남홀덤펍 헬로카지노추천 home.
*8. Energy Management System (EMS): Monitors and controls energy via a network, including making 릴게임프로그램 고바카라추천 energy usage, including electric power usage, transparent, and optimally manages 릴천지게임 *8.해남홀덤펍 스타바카라주소
*9. Power Producer and Supplier (PPS): Designated scale 해남홀덤펍 간혹가다 power products, generally known as new power suppliers. A 릴게임프로그램 해외카지노 company 릴게임프로그램 *9.obtains a license and newly enters the electric power industry.
*10. Electric power using a Feed-in Tariff (FIT) 해남홀덤펍 정통카지노추천 source 릴게임프로그램 *10.whereby the purchase price of renewable energy is 릴게임프로그램 decided by law) 해남홀덤펍 세븐카지노주소
*11. Virtual Power Plant Response (VPP): Network or system that centrally controls a number of small solar 해남홀덤펍 엄지알바 power or 해남홀덤펍 other generators as 해남홀덤펍 서비스 if 릴게임프로그램 티렌트 it were 릴게임프로그램 19멍 one large power 바카라게임룰 *11.
*12. A resource aggregator collects energy resources from consumers for energy 해남홀덤펍 에이플러스바카라주소 producers (power transmission and distribution companies, retail 카지노위키 *12.power companies, and renewable 릴게임프로그램 썬시티바카라추천 energy 해남홀덤펍
